GlaxoSmithKline (GSK) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has completed a significant clinical study titled ‘Study in Pediatrics With HypEREosinophilic Syndrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback